Lassa Virus -Like Particles

Item No. Antibody Designation Clone Number Applications
LASVLP-II-001 LASVirus – Like Particles lineage II WB
LASVLP-III-002 LASVirus – Like Particles lineage III WB
LASVLP-IV-003 LASVirus – Like Particles lineage IV WB


Ordering process:
1. Please complete the proposal request for intended use of the reagent. Upon approval
we will request execution of a Material Transfer Agreement
2. Two-way execution of a Material Transfer Agreement
3. Ordering and shipment of the reagent

Disclaimer: For Research Use only.
1. Most neutralizing human monoclonal antibodies target novel epitopes requiring both Lassa virus glycoprotein subunits.
Robinson JE, Hastie KM, Cross RW, Yenni RE, Elliott DH, et al. Nat Commun. 2016 May 10;7:11544. doi: 10.1038/ncomms11544.
PMID: 27161536
2. Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus. Andersen KG, Shapiro BJ, Matranga CB, Sealfon R, Lin AE, et al. Cell. 2015 Aug 13;162(4):738-50. doi: 10.1016/j.cell.2015.07.020.
PMID: 26276630

Order Lassa Virus Reagents Here